Autor/in Giagounidis, A 2 Götze, K 2 Haase, D 2 Letsch, A 2 Platzbecker, U Schlenk, R F 2 Shirneshan, K Braulke, F 1 Büsche, G 1 Ganser, A 1 Jann, J-C 1 Mossner, M 1 Nolte, F 1 Nowak, D 1 Schuler, E 1 alle zeigenListe einklappen
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5) Schuler, E Giagounidis, A Haase, D Shirneshan, K Büsche, G Platzbecker, U Nolte, F 2016 - Forschungsinformationssystem des UKE
Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS) Mossner, M Jann, J-C Nowak, D Platzbecker, U Giagounidis, A Götze, K Letsch, A 2016 - Forschungsinformationssystem des UKE
